Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-04-20

Opinion for Novartis AG (NVS-N)

Signal Price Bias Subject Owned
BUY $73.620 BULLISH on GLOBAL STOCKS GLOBAL Yes

It is a really strong global pharma company.  They are turning around their eye care business acquisition and their cardiac drug which had a bungled launch.  If they are successful they will do quite well.  It could be a blockbuster.

Mark Grammer
Managing Dir. & Portfolio Manager, Gluskin Sheff & Associates

No Comments.


You must be logged in to comment.